X0609 4 2026-04-22 0001830487 Pharvaris N.V. PHVS 0001973705 Lesage Anne false 1 CRANBERRY HILL SUITE 400 LEXINGTON MA 02421 false true false false Chief Early Development true Common Stock 2026-04-22 4 M false 500 2.59 A 56950 D Common Stock 2026-04-22 4 S false 500 30.0000 D 56450 D Common Stock 2026-04-22 4 M false 7000 8.05 A 63450 D Common Stock 2026-04-22 4 S false 7000 30.0517 D 56450 D Common Stock 2026-04-22 4 S false 7000 30.0511 D 156969 I GrayMatters Consulting B.V. Common Stock 2026-04-23 4 S false 100 30.0300 D 156869 I GrayMatters Consulting B.V. Common Stock 2026-04-23 4 M false 100 2.59 A 56550 D Common Stock 2026-04-23 4 S false 100 30.0300 D 56450 D Stock Option (Right to Buy) 2.59 2026-04-22 4 M false 500 0 D 2030-01-01 Common Stock 500 15972 D Stock Option (Right to Buy) 8.05 2026-04-22 4 M false 7000 0 D 2031-02-05 Common Stock 7000 113000 D Stock Option (Right to Buy) 2.59 2026-04-23 4 M false 100 0 D 2030-01-01 Common Stock 100 15872 D This is a scheduled exercise and sale from 10b5-1 trading plan. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.13. These shares were sold in multiple transactions at prices ranging from $30.03 to $31.03. 25% of the option vested on January 1, 2020 with the remaining shares vesting in 1/48 monthly installments thereafter. 25% of the option vested on February 5, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter. /s/ Marnus Nel, Attorney-in-Fact for Anne Lesage 2026-04-24